Synmosa Biopharma Corporation (4114)
Market Closed
16 Oct, 05:30 AM
TWSE 
NT$
30. 30
+0.15
+0.4975%
NT$
- Market Cap
- P/E Ratio
126% Div Yield
1.63M Volume
- Eps
NT$ 30.15
Previous Close Want to track 4114 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Synmosa Biopharma Corporation (4114) Statistics
Valuation metrics
Market Cap -
Enterprise value 17.9B
Trailing P/E (ttm) 19.08
Forward P/E -
PEG ratio -30.34
Price/Sales (ttm) 2.44
Price/Book (mrq) 1.68
Enterprise Value/Revenue 2.68
Enterprise Value/EBITDA 17.35
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 931.32K
Average volume (90 days) 1.01M
Price summary
52-Week low 27.55
52-Week high 32.41
Beta -
50-Day moving average 29.65
200-Day moving average 30.5
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 0.85
Trailing annual dividend yield 0.0281%
5-Year annual dividend yield -
Payout ratio 0.35
Dividend Date 20 Aug 2026
Ex-Dividend Date 17 Jul 2026
Last split factor 1,079:1,000
Last split Date 17 Jul 2026
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.12%
Operating margin 0.11%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.09%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 13.89
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 1.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.78
Total debt (mrq) -
Total Debt/Equity (mrq) 0.39
Current ratio (mrq) 2.03%
Book value per share (mrq) 20.53
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
